Skip to content

Clinical trial for verifying the accuracy of HPV nucleic acid detection with human papillomavirus (HPV) nucleic acid detection kit (PCR fluorescent probe method) of medium and high risk types (18 species)

Clinical trial for verifying the accuracy of HPV nucleic acid detection with human papillomavirus (HPV) nucleic acid detection kit (PCR fluorescent probe method) of medium and high risk types (18 species)

Status
Recruiting
Phases
Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100052652
Enrollment
Unknown
Registered
2021-11-03
Start date
2021-11-01
Completion date
Unknown
Last updated
2022-08-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical diseases

Interventions

Sponsors

Obstetrics and Gynecology Hospital Affiliated to Medical College of Zhejiang University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
21 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Cervical samples from women aged >= 21 years in outpatient and/or inpatient patients; 2. The sample information is complete, clearly marked, and traceable to the original record.

Exclusion criteria

Exclusion criteria: 1. Other circumstances that the investigator considers unsuitable to participate in this clinical trial; 2. Samples that do not meet the sample requirements of this protocol or the instructions of the assessment reagent/comparison reagent; 3. Repeated samples from the same patient; 4. Contaminated samples.

Design outcomes

Primary

MeasureTime frame
High risk human papillomavirus infection;Positive coincidence rate;Negative coincidence rate;over-all coincident rate;consistency;

Countries

China

Contacts

Public ContactWang Hui

Obstetrics and Gynecology Hospital Affiliated to Medical College of Zhejiang University

5198008@zju.edu.cn+86 13958160137

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026